MENU
Showcases Stock ranks Forex

Johnson & Johnson (JNJ)
158.58  0.62 (0.39%) 03-28 15:36
Open: 158.2 Pre. Close: 157.96
High: 159.14 Low: 158.11
Volume: 2,762,819 Market Cap: 381,983(M)
Stock Technical Analysis
Overall:     
Target: Six months: 186.79
One year: 190.51
Support: Support1: 154.76
Support2: 128.76
Resistance: Resistance1: 159.92
Resistance2: 163.11
Pivot: 157.94
Moving Averages: MA(5): 156.52
MA(20): 158.46
MA(100): 156.88
MA(250): 159.71
MACD: MACD(12,26): -0.71
Signal(12,26,9): -0.59
%K %D: %K(14,3): 31.46
%D(3): 18.48
RSI: RSI(14): 51.39
52-Week: High: 175.97
Low: 144.95
Change(%): 3.3
Average Vol(K): 3-Month: 6974
10-Days: 6694
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 158.489 - 159.246 159.246 - 159.934
Low: 153.548 - 154.442 154.442 - 155.253
Close: 156.491 - 157.957 157.957 - 159.287
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

[ JNJ ] has closed below upper band by 44.7%. Bollinger Bands are 26.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Company profile
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Stock chart
Stock News
Thu, 28 Mar 2024
Jets owner Woody Johnson denies 'irresponsible' NFL Network report about 'heated conversation' with Robert Saleh - New York Post

Thu, 28 Mar 2024
House to send DHS Secretary Mayorkas' impeachment to Senate on April 10, Speaker Mike Johnson says - NBC News

Thu, 28 Mar 2024
Bills sign DT Austin Johnson to one-year deal - BuffaloBills.com

Thu, 28 Mar 2024
Question of whether Woody Johnson, Robert Saleh had "very heated conversation" becomes very hot topic - Yahoo Sports

Thu, 28 Mar 2024
Will Diontae Johnson help fix Bryce Young, Panthers' offense? - ESPN

Thu, 28 Mar 2024
Democrats see rescuing Speaker Johnson as best bet for Ukraine aid - The Hill

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Outperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - General
Shares Out. (M) 2410.00
Shares Float (M) 2400.00
% Held by Insiders 0.09
% Held by Institutions 71.28
Shares Short (K) 14850
Shares Short Prior Month (K) 12300
Stock Financials
EPS 5.200
Book Value (p.s.) 28.570
Profit Margin 41.28
Operating Margin 22.11
Return on Assets (ttm) 8.3
Return on Equity (ttm) 18.3
Qtrly Rev. Growth 7.3
Gross Profit (p.s.)
Sales Per Share 35.336
EBITDA (p.s.) 12.768
Qtrly Earnings Growth 10.60
Operating Cash Flow (M) 22790.00
Levered Free Cash Flow (M) 19790.00
Stock Valuation
PE Ratio 30.47
PEG Ratio 3.11
Price to Book value 5.55
Price to Sales 4.48
Price to Cash Flow 16.75
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android